insulin glargine + liraglutide

This is a combination of two antidiabetic agents, insulin glargine and liraglutide. Insulin glargine is a long-acting basal insulin analog that helps regulate blood glucose by facilitating cellular uptake of glucose and suppressing hepatic glucose production. Liraglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist that increases endogenous insulin secretion, decreases glucagon secretion, slows gastric emptying, and reduces appetite. The combination aims to improve glycemic control in adults with type 2 diabetes mellitus by targeting both fasting and postprandial blood sugar levels through complementary mechanisms of action.